Cabka (CABKA) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
23 Nov, 2025Executive summary
Revenues for H1 2025 were €90 million, down 2% year-over-year, with US sales up 9% and European sales down 8% due to market volatility, but commercial momentum and operational efficiencies are improving.
The Shift program delivered cost savings, improved cash flow, and enhanced operational efficiency, focusing on inventory reduction and disciplined capital expenditure.
U.S. operations are recovering, with new client wins, improved utilization, and market share gains following past disruptions.
Net result was a loss of €4.7 million, compared to a €1.9 million loss in H1 2024, with basic EPS at -0.19.
Management transition: new CFO Mark Lettrie joins in September, ensuring continuity.
Financial highlights
Gross operating margin improved by over 200 basis points to 51.7% from 49.5% year-over-year.
Operational EBITDA was €9.1 million (10.1% of sales), down 13% year-over-year, mainly due to inventory reduction.
Operating expenses decreased by 1%, with €1.1 million in underlying savings.
Capital expenditure was €5.4 million, a 42% reduction from the prior year, split between maintenance and expansion.
Net debt stable at €72.3 million as of June 30, 2025; gross debt reduced to €75.3 million.
Cash flow from operating activities improved to €0.2 million from -€4.4 million year-over-year.
Outlook and guidance
Confident in meeting full-year 2025 guidance, expecting results at least in line with 2024 and improved cash flow profile.
Shift plan expected to contribute €2 million in annualized benefits and further lower capital expenditure.
Commercial momentum, new contracts, and growing customer interest in reusable packaging are expected to drive H2 growth.
Capital Markets Day in November 2025 will provide updates on strategic roadmap and medium-term targets.
Latest events from Cabka
- EBITDA margin rose to 11.7% as net loss narrowed and net debt fell, despite a 1% revenue dip.CABKA
H2 20255 Mar 2026 - Sales fell 11% YoY, but gross margin rose to 50.5% and European segments grew.CABKA
H1 20241 Feb 2026 - 2024 sales fell 8% but margin rose to 50.9%; portfolio growth and cost control prioritized.CABKA
H2 202426 Dec 2025 - Staged plan targets €215M+ revenue by 2028 and €300M+ with margin expansion by 2030.CABKA
CMD 202519 Nov 2025 - Stable Q3 sales and improved EBITDA margin, with 2025 outlook matching prior year.CABKA
Q3 2025 TU21 Oct 2025 - Q1 2025 sales held steady at €44.1 million, with stable outlook despite market volatility.CABKA
Q1 2025 TU19 Jun 2025 - Targets €300m revenue and 15–17% EBITDA margin by 2030, led by innovation and sustainability.CABKA
CMD 202413 Jun 2025 - Q3 sales up 8% year-over-year, with full-year guidance reaffirmed amid segment growth.CABKA
Q3 2024 TU13 Jun 2025